Last 12,000 KRW
Change Today 0.00 / 0.00%
Volume 105.3K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:26 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Year over year, Daewon Pharmaceutical Co. Ltd. has been able to grow revenues from 138.2B KRW to 158.9B KRW. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 48.34% to 47.27%. This was a driver that led to a bottom line growth from 9.6B KRW to 12.3B KRW.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2010
Press
Release

KRW
Dec 31
2011
KRW
Dec 31
2012
KRW
Dec 31
2013
KRW
4 Year
Trend
Revenues144,696.1138,874.7138,168.5158,878.9
Other Revenues--0.0----
TOTAL REVENUES144,696.1138,874.7138,168.5158,878.9
Cost of Goods Sold--62,757.566,792.175,100.0
GROSS PROFIT144,696.176,117.271,376.483,778.8
Selling General & Admin Expenses, Total--52,762.951,130.360,470.4
R&D Expenses--5,680.74,785.55,753.9
Depreciation & Amortization, Total--737.2931.2975.8
Other Operating Expenses124,626.63,554.81,059.21,034.3
OTHER OPERATING EXPENSES, TOTAL124,626.662,735.657,906.368,234.5
OPERATING INCOME20,069.513,381.613,470.115,544.3
Interest Expense---285.6-226.5-126.1
Interest and Investment Income--356.0694.7751.7
NET INTEREST EXPENSE--70.4468.2625.6
Currency Exchange Gains (Loss)--62.6-109.2155.0
Other Non-Operating Income (Expenses)130.6-205.6221.6278.8
EBT, EXCLUDING UNUSUAL ITEMS20,200.113,309.014,050.816,603.8
Gain (Loss) on Sale of Investments---64.9-737.7-63.5
Gain (Loss) on Sale of Assets---115.1-10.6-172.0
Other Unusual Items, Total---600.0-747.3-766.1
EBT, INCLUDING UNUSUAL ITEMS20,200.112,529.112,555.215,602.2
Income Tax Expense8,354.43,272.22,789.13,368.9
Minority Interest in Earnings--179.4-151.487.7
Earnings from Continuing Operations11,845.79,256.99,766.212,233.3
NET INCOME11,845.79,436.49,614.812,320.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS11,845.79,436.49,614.812,320.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS11,845.79,436.49,614.812,320.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 12,000.00 KRW 0.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 15.1x
Price/Sales 1.1x
Price/Book 1.5x
Price/Cash Flow 14.8x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.